At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you.
The Associate Director, Strategic Content Development, Global Medical Affairs – Alzheimer’s Disease, in the Neurology Business Group (NBG) provides medical leadership and accountability to the AD portfolio and continued support as a key partner to Clinical Development, Real World Evidence and Commercial Operations.
The incumbent will provide disease area expertise in AD, advance medical value, execute strategic publication and medical education initiatives, as well as ensure global-regional, and cross-functional alignment and collaboration with all stakeholders. Under the direction of the Director, Strategic Scientific Content Development, Global Medical Affairs, this role is responsible for developing and executing the global medical affairs plan, including peer-reviewed review/perspective publications, medical education, support of symposia at major AD congresses and medical advisory boards, and scientific communication.
The Associate Director is a key member of the NBG group responsible for developing and maintaining excellence in global medical affairs activities. This incumbent will utilize their expert medical and scientific knowledge in the AD disease area to generate and publish medical value that fills knowledge gaps and facilitates the appropriate and optimal use of Eisai medicines to improve patient outcomes and fulfill the hhc mission.
These responsibilities require broad scientific training with subject matter expertise in AD and a record of scientific interest and publications. Experience in the pharmaceutical industry and a background in medical affairs is highly preferred. The successful candidate will have advanced written and verbal communication skills, be a deep and strategic thinker while also being an effective project executor.
Essential Functions
Work with Director, Strategic Medical Content Development, Global Medical Affairs to strategize, develop, and coordinate strategic medical plans for the global Alzheimer's therapeutic area.Coordinate strategic content projects in the AD space with original contribution to drafting review/perspective articles for peer-reviewed journals; Liaise with external co-authors, internal stakeholders, and external medical writers for development and integration of highest quality medical content.Provide medical expertise and tactical input into the overall publication strategy; Ensure that all strategic publication materials are accurate, compliant, balanced, and of the highest quality; Work with cross-functional teams and ensure that all communication materials are developed in a manner consistent with relevant guidelines and Eisai’s policies.Formulate medical content and execute broad-based activities supporting the Global Medical Affairs team, including authoring strategic publications, developing educational programs, planning advisory boards, executing symposia and other congress-related activities as deemed appropriate.Participate as an ad-hoc member of Eisai’s Global Launch cross-functional team for Alzheimer’s Disease; Strengthen Eisai’s medical reputation through successful management of medical dimensions of products.Represent Alzheimer’s Global Medical Affairs at internal and external activities, congresses, meetings, initiatives, and workgroups during global travel assignments.Lead the development of strategic plans for medical publication and provide medical expertise towards the development and execution of AD education in alignment with medical strategy and related brand plans.Serve as medical/scientific subject matter expert and provide direction for assigned products including (but not limited to) CRC, scientific communications, publication planning/review, advisory boards, health outcomes plans, MSL activities, speaker programs, investigator-initiated research and CME grant reviews or other internal key business processes.Continuously ensures compliance with Eisai policies and procedures for all activities undertaken and monitors various government and industry guidelines to best practices.Requirements
This position requires a dynamic individual with a PhD with training or work experience in Alzheimer’s disease. Industry experience is preferred but not required.Demonstrated track record and authorship of peer-reviewed publications in AD research; Experience with authorship of publication and project management required.Experience in medical affairs preferred but not required.Knowledge of the neuroscience and neurobiology of neurodegeneration, particularly Alzheimer disease.Knowledge of KOLs in the AD therapeutic area.In-depth knowledge of clinical practice in Alzheimer’s disease. Drug development experience, preferably in AD, and thorough understanding of clinical research methodology is preferred.Must understand and adhere to industry-related guidelines relevant to medical affairs, medical information, medical education, and Publications.Experience directing external agencies, vendors, and consultants in support of the development of materials and coordination of global activities preferred.Strong interpersonal, team building and communication skills.Excellent analytical and data managing skills.#LI-HC1
#IND-123
Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.
Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:
Right To Work
E-Verify Participation